A practical reference on 生长激素释放激素: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-05-06 and is reviewed periodically as new material appears.
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
The peptide is synthesized chemically rather than extracted from biological sources. Solid-phase synthesis builds the chain from the C-terminus toward the N-terminus, after which the hexenoyl group is attached. Purity is typically assessed by high-performance liquid chromatography, and identity is confirmed by mass spectrometry. Regulatory review of the finished product focuses on these analytical controls, since small deviations in sequence or modification can change biological activity. Questions about long-term effects on the pituitary axis remain areas of continued investigation.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
| Property | Value | Notes |
|---|---|---|
| Primary target | Growth hormone-releasing hormone receptor | Located on anterior pituitary somatotroph cells. |
| Receptor class | G protein-coupled receptor | Activation increases intracellular cyclic AMP. |
| Main downstream hormone | Growth hormone and insulin-like growth factor 1 | Growth hormone release precedes IGF-1 elevation. |
| Primary studied effect | Reduction in visceral adipose tissue | Measured by computed tomography in clinical trials. |
| Approximate half-life | 26–38 minutes after subcutaneous administration | Values vary by assay and study population. |
Tesamorelin binds the growth hormone–releasing hormone receptor on pituitary somatotroph cells. The receptor signals through the Gs protein, raising intracellular cAMP and activating protein kinase A. That cascade triggers release of stored growth hormone in pulses rather than a steady stream. Because the drug acts at the receptor that normally controls this process, its effect depends on the body's own signaling architecture rather than on a synthetic pathway. The resulting hormone profile reflects the timing of each pulse, not only its size.
Measured responses usually involve growth hormone and insulin-like growth factor 1, known as IGF-1. Growth hormone rises in bursts and is difficult to sample reliably, while IGF-1 shifts more slowly and can be assessed from a single blood draw. Studies therefore treat IGF-1 as the more practical pharmacodynamic marker. Both are indirect, showing that the receptor was engaged rather than that the peptide reached a particular concentration. Direct exposure measurement requires an assay aimed at the molecule itself.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
Questions remain about how much of the observed fat reduction reflects direct GHRH-receptor signaling versus the downstream growth hormone and IGF-1 surge. It is also unclear whether the compound produces meaningful benefit in populations without lipodystrophy, since trials in cognitive impairment did not reach their stated goals. Long-term effects on glucose metabolism and on cardiovascular outcomes are not fully characterized. Published work generally describes effects on surrogate markers rather than on hard clinical endpoints, and independent replication of some findings is limited.
Tesamorelin acts on the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in intracellular cyclic AMP, which in turn opens ion channels and raises calcium concentrations, leading to release of stored growth hormone into the bloodstream. Because the peptide works through the same receptor as the body's own GHRH, the resulting secretion follows a pulsatile pattern rather than a continuous elevation. The N-terminal modification slows enzymatic breakdown, so the signal persists longer than it would with the unmodified hormone.
Growth hormone released from the pituitary stimulates the liver and other tissues to produce insulin-like growth factor 1, a stable circulating protein that serves as a practical marker of activity. Clinical studies therefore track IGF-1 concentrations alongside the hormone itself, and they commonly measure body composition with imaging rather than relying on body weight alone. Visceral adipose tissue, the fat surrounding abdominal organs, is quantified by computed tomography in the studies that supported approval. Adverse effects reported in trials include injection-site reactions, joint pain, and increases in blood glucose, which is why monitoring accompanies use.
监管记录显示，特沙莫瑞林于 2010 年在美国首次获得批准，用于人类免疫缺陷病毒感染相关的脂肪营养不良患者。批准依据来自降低内脏脂肪的临床试验，而非体重或瘦体重的普遍改善。后续出现了不同制剂版本，但其核心适应症保持一致。关于长期心血管结局和死亡率影响，现有证据仍不充分。
在临床研究之外，特沙莫瑞林常被讨论为生长激素分泌促进剂，但这一说法需要限定。它并不等同于生长激素本身，也不属于普通减重药物。部分研究关注其减少腹部脂肪和改善脂质谱的潜力，另一些研究则关注胰岛素抵抗和 IGF-1 升高等信号。这些效应的临床意义仍在评估中，尚未形成统一结论。
=== Category:EC 2.1 (transfer one-carbon groups, Methylase) === Category:EC 2.1.1 Catechol-O-methyl transferase EC 2.1.1.6 DNA methyltransferase EC 2.1.1.72, EC 2.1.1.113, EC 2.1.1.37 Histone methyltransferase EC 2.1.1.43, EC 2.1.1.125 Category:EC 2.1.3 Aspartate transcarbamoylase EC 2.1.3.2 Ornithine transcarbamoylase EC 2.1.3.3
Hours after Palacios' statement, Free Peru's General Secretary Vladimir Cerrón said "When you lose faith in your militancy, you force yourself to look for strength with the mercenaries." Cerron also quoted Borges by saying "traitors are reliable because they never change." Afterward, El Comercio released a paper claiming that the Free Peru caucus voted as a split group nearly 50% of the time. On 29 November 2021, Vladimir Cerrón announced that Free Peru would hold an extraordinary national assembly on 5 December 2021, to determine the party's stance on the impeachment motion, the government, and other topics. On 6 December 2021, Free Peru concluded its extraordinary national assembly by announcing that it would vote unanimously against impeachment. Free Peru stated that it has "serious discrepancies" with the "caviar" government of Castillo, but also accused the pro-impeachment movement of being fascist and anti-democratic. Additionally, Free Peru also reaffirmed that it considered Cuba, Venezuela, and Bolivia to have democratic governments.
While Fenn was working with Monsanto, the company's research was focused on the production of phosphoric acid and polychlorinated biphenyls (PCBs). Fenn and his colleagues at Monsanto were largely unaware of the health hazards posed by PCBs, indeed because of their inertness, they "practically bathed in the stuff". After spending several more years doing various industrial research, Fenn was looking to get back into the academic world. He had the opportunity to go to Princeton University, where he became the director of Project SQUID. Fenn did not start his Nobel-winning research until later in his career. He was semi-retired when he first published his research on electrospray ionization for mass spectrometry. Fenn felt that his work in electrospray ionization received "a kick in the pants" when proteomics emerged. In 2001, more than 1700 papers on proteomics were published, many using electrospray ionization. Electrospray ionization provides a way to get accurate information about the mass of a large molecule very quickly, even when it is in a mixture of other molecules. The liquid sample is introduced into an electrospray source (at atmospheric pressure) and desolvated with a flow of heated nitrogen gas. This forms small droplets which evaporate in a region under vacuum, which increases the charge on the droplets. For large molecules like proteins, this often results in multiply charge species. Increasing the charge on the molecules, decreased the mass-to-charge ratio, which allows the mass to be more easily determined.
Alice in Chains (often abbreviated as AiC) is an American rock band formed in Seattle in 1987. Since 2006, the band's lineup has consisted of vocalist/guitarists Jerry Cantrell and William DuVall, bassist Mike Inez, and drummer Sean Kinney. Original vocalist Layne Staley died in 2002, and former bassist Mike Starr left in 1993. Often associated with grunge music, Alice in Chains' sound and style is rooted in heavy metal. The band is known for its distinctive vocal style, which often included the harmonized vocals between Staley and Cantrell (and later Cantrell and DuVall). Alice in Chains' original lineup consisted of Cantrell, Kinney, Staley, and Starr. They took the name from Staley's previous band, Alice N' Chains. The band rose to international fame as part of the grunge movement of the early 1990s, along with other Seattle bands such as Nirvana, Pearl Jam, and Soundgarden. They broke through on MTV and mainstream rock radio with the single "Man in the Box" (from their 1990 debut album Facelift). After releasing the EP Sap in early 1992, the band achieved major mainstream and commercial success with their follow-up album Dirt later that same year. Dirt contained the popular singles "Rooster" and "Would?", among others. Starr was replaced on bass by Inez in early 1993. The following two records, 1994's Jar of Flies (which included the popular single "No Excuses") and 1995's Alice in Chains (also contained radio hits such as "Heaven Beside You" and "Grind"), both topped the US Billboard 200 chart and earned the band several Grammy Award nominations.
Sources: en.wikipedia.org
Sir John Christopher Willoughby was second in command and took command of the expedition when the two columns united northwest of Johannesburg on 30 December. Although Jameson's men had cut the telegraph wires to Cape Town, they had failed to cut the telegraph wires to Pretoria (cutting a fence by mistake). Accordingly, news of his incursion quickly reached Pretoria and Jameson's armed column was tracked by Transvaal forces from the moment that it crossed the border. The Jameson armed column first encountered resistance very early on 1 January when there was a very brief exchange of fire with a Boer outpost. Around noon the Jameson armed column was around twenty miles further on, at Krugersdorp, where a small force of Boer soldiers had blocked the road to Johannesburg and dug in and prepared defensive positions. Jameson's force spent some hours exchanging fire with the Boers, losing several men and many horses in the skirmish. Towards evening the Jameson armed column withdrew and turned south-east attempting to flank the Boer force. The Boers tracked the move overnight and on 2 January, as the light improved, a substantial Boer force with some artillery was waiting for Jameson at Doornkop. The tired raiders initially exchanged fire with the Boers, losing around thirty men before Jameson realized the position was hopeless and surrendered to Commandant Piet Cronjé. The raiders were taken to Pretoria and jailed.
positional cloning Also map-based cloning. A strategy for identifying and cloning a candidate gene based on knowledge of its locus or position alone and with little or no information about its products or function, in contrast to functional cloning. This method usually begins by comparing the genomes of individuals expressing a phenotype of unknown provenance (often a hereditary disease) and identifying genetic markers shared between them. Regions defined by markers flanking one or more genes of interest are cloned, and the genes located between the markers can then be identified by any of a variety of means, e.g. by sequencing the region and looking for open reading frames, by comparing the sequence and expression patterns of the region in mutant and wild-type individuals, or by testing the ability of the putative gene to rescue a mutant phenotype.
Prominent Romanian painters include: Nicolae Grigorescu, Ștefan Luchian, Ion Andreescu Nicolae Tonitza, and Theodor Aman. Notable Romanian classical composers of the 19th and 20th centuries include: Ciprian Porumbescu, Anton Pann, Eduard Caudella, Mihail Jora, Dinu Lipatti, and especially George Enescu. The annual George Enescu Festival is held in Bucharest in honour of the 20th-century composer. Contemporary musicians like Angela Gheorghiu, Gheorghe Zamfir, Inna, Alexandra Stan, and many others have achieved various levels of international acclaim. From the late 2000s through the early 2010s, the Romanian popcorn music style had established itself in the international mainstream. At the Eurovision Song Contest Romanian singers achieved third place in 2005 and 2010. In cinema, several movies of the Romanian New Wave have achieved international acclaim. At the Cannes Film Festival, The Death of Mr. Lazarescu by Cristi Puiu won the Prix Un Certain Regard in 2005, while 4 Months, 3 Weeks and 2 Days by Cristian Mungiu won the festival's top prize, the Palme d'Or, in 2007. At the Berlin International Film Festival, Child's Pose by Călin Peter Netzer won the Golden Bear in 2013. The list of World Heritage Sites includes six cultural sites located within Romania, including eight painted churches of northern Moldavia, eight wooden churches of Maramureș, seven villages with fortified churches in Transylvania, the Horezu Monastery, and the Historic Centre of Sighișoara.
Sources: en.wikipedia.org
== Pharmacodynamics == Tiapride is a dopamine D2 and D3 receptor antagonist. It is more selective than other neuroleptic drugs such as haloperidol and risperidone, which not only target four of the five known dopamine receptor subtypes (D1-4), but also block serotonin (5-HT2A, 2C), α1- and α2-adrenergic, and histamine H1 receptors. Compared to these drugs, tiapride has a relatively moderate affinity for its target receptors, displacing 50 percent of 3H-raclopride binding at a concentration of 320 nM at D2 receptors and a concentration of 180 nM at D3 receptors. Tiapride displays a relatively high regional selectivity for limbic areas. One study found that, in contrast with haloperidol, which displays equal affinity for receptors in the rat limbic system and striatum, tiapride shows over three times as much affinity for limbic areas than striatal areas. Another study in rats found tiapride's affinity for the septum, a limbic region, to be over thirty times as high as for the striatum. Efficacy at the D2 receptor is moderate, with 80 percent of receptors occupied even in the presence of excess tiapride concentrations.
Block copolymers are made up of blocks of different polymerized monomers. For example, polystyrene-b-poly(methyl methacrylate) or PS-b-PMMA (where b = block) is usually made by first polymerizing styrene, and then subsequently polymerizing methyl methacrylate (MMA) from the reactive end of the polystyrene chains. This polymer is a "diblock copolymer" because it contains two different chemical blocks. Triblocks, tetrablocks, multiblocks, etc. can also be made. Diblock copolymers are made using living polymerization techniques, such as atom transfer free radical polymerization (ATRP), reversible addition fragmentation chain transfer (RAFT), ring-opening metathesis polymerization (ROMP), and living cationic or living anionic polymerizations. An emerging technique is chain shuttling polymerization. The synthesis of block copolymers requires that both reactivity ratios are much larger than unity (r1 >> 1, r2 >> 1) under the reaction conditions, so that the terminal monomer unit of a growing chain tends to add a similar unit most of the time. The "blockiness" of a copolymer is a measure of the adjacency of comonomers vs their statistical distribution. Many or even most synthetic polymers are in fact copolymers, containing about 1-20% of a minority monomer. In such cases, blockiness is undesirable. A block index has been proposed as a quantitative measure of blockiness or deviation from random monomer composition.
== Chemistry == Bromantane is an adamantane derivative. It is also known as adamantylbromphenylamine, from which its name was derived. Closely related adamantanes with similar effects include adapromine, amantadine, chlodantane, gludantane (gludantan), memantine, and rimantadine.
==== Development of Dishonored (2012) ==== Starting in 2009, Antonov was the visual design director of Arkane Studios' Dishonored, a first-person stealth action-adventure game that released in 2012. During the game's development, he worked with the other heads of its art team, Sébastien Mitton and Jean-Luc Monnet, to restructure the team and improve their creative processes, making what Colantonio has called "a world-class team of artists that could rival any top team in the world". The game was in pre-production for three years, as every asset in Dishonored's world was created specifically for the project, rather than being borrowed from asset libraries. The team at Arkane wanted the game to have a "contemporary and cool" setting with a "real", "politically incorrect" tone. Antonov specifically wanted to make a realistic game with a retrofuturistic aesthetic set in the past. In 2012, he told Eurogamer that the modern gaming industry was not exploring that type of style—an exception being 2007's BioShock—and was focusing too much on war games, and New York City as a setting. Furthermore, he wanted Dishonored to have a specific, stripped-down gameplay experience, saying modern games contained too many mechanics from different genres, like "narration, music, contemplation, [and] shooting", which caused them to "lose the experience" originally intended by their designers.
Sources: en.wikipedia.org
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Binding stimulates cyclic AMP signaling and growth hormone secretion. This is the same receptor used by endogenous GHRH.
It does not act directly on adipose tissue as a primary mechanism. Instead, it increases endogenous growth hormone, which then influences lipolysis and fat distribution. The reduction in visceral fat is an indirect pharmacodynamic effect.
Tesamorelin acts upstream at the pituitary to amplify natural pulsatile growth hormone release. Growth hormone injections provide exogenous hormone and bypass pituitary regulation. The two approaches therefore differ in feedback control and hormonal dynamics.
It shares the 44-residue sequence of human GHRH but carries an added trans-3-hexenoyl group at its N-terminus. That addition does not occur in the natural hormone and serves mainly to resist enzymatic breakdown. The receptor target and signaling pathway remain the same.